Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia.
Saved in:
| Title: | Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. |
|---|---|
| Authors: | Tsubaki M; Laboratory of Pharmacotherapy, Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, 8-53 Hamanocho, Takamatsu, 760-8542, Kagawa, Japan., Matsuo T; Laboratory of Pharmacotherapy, Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, 8-53 Hamanocho, Takamatsu, 760-8542, Kagawa, Japan., Komori R; Laboratory of Pharmacotherapy, Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, 8-53 Hamanocho, Takamatsu, 760-8542, Kagawa, Japan. |
| Source: | Oncology research [Oncol Res] 2026 Apr 22; Vol. 34 (5), pp. 7. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
